In conclusion, this study demonstrates that the combination of SMI‐16a and ABT888 enhances NK cell‐mediated tumor killing through the NKG2D/MICA signaling axis, promoting DNA damage and resulting in a stronger antitumor response against multiple myeloma. This evidence concerns the gene KLRK1 and neoplasm.